Acura Pharmaceuticals Inc. (ACUR) rose steadily during the first 45 minutes of trade Tuesday, before settling into a range. The stock closed up by 1.04 at $3.49 on the highest volume of the year.
Acura Pharmaceuticals added to yesterday's sharp gains and set over an 8-month high. The company announced the launch of Nexafed on Monday, a cold medicine with abuse-deterrent technology.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org